Article · 12 Jun 2026
Conference abstract
Use of contingency management incentives to improve completion of Hepatitis B vaccination in people undergoing treatment for heroin dependence: A cluster randomized trial
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Poor adherence to treatment diminishes its individual and public health benefit. Financial incentives, provided on the condition of treatment attendance, could address this problem. Injecting drug users are a high-riskgroup for hepatitis B virus (HBV) infection and transmission, but adherence to vaccination program is poor. We aimed to assess whether contingency management delivered in routine clinical practice increased the completion of HBV vaccination in individuals receiving opioid substitution therapy. Methods: In our cluster randomised controlled trial, we enrolled participants at 12 National Health Service drug treatment services in the UK that provided opioid substitution therapy and nurse-led HBV vaccination with a super accelerated schedule (vaccination days 0, 7, and 21). Clusters were randomly allocated 1:1:1 to provide vaccination without incentive (treatment as usual), with fixed value contingency management (three £10 vouchers), or escalating value contingency management (£5, £10, and £15 vouchers). Both contingency management schedules rewarded on-time attendance at appointments. The primary outcome was completion of clinically appropriate HBV vaccination within 28 days. We also did sensitivity analyses that examined vaccination completion with full adherence to appointment times and within a 3 month window. The trial is registered with Current Controlled Trials, number ISRCTN72794493. Findings: Between March 16, 2011, and April 26, 2012, we enrolled 210 eligible participants. Compared with six (9%) of 67 participants treated as usual, 35 (45%) of 78 participants in the fixed value contingency management group met the primary outcome measure (odds ratio 12?1, 95% CI 3?7-39?9; p<0?0001), as did 32 (49%) of 65 participants in the escalating value contingency management group (14?0, 4?2-46?2; p<0?0001). These differences remained significant with sensitivity analyses. Interpretation: Modest financial incentives delivered in routine clinical practice significantly improve adherence to and completion of HBV vaccination programs in patients receiving opioid substitution therapy. Achievement of this improvement in routine clinical practice should now prompt actual implementation. Drug treatment providers should employ contingency management to promote adherence to vaccination programs. The effectiveness of routine use of contingency management to achieve long-term behaviour change remains unknown. PDF HTML
Keywords
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Liver.
Article · 12 Jun 2026
Rhythms of Digestion: Understanding the Gallbladder in Human Physiology
Article · 12 Jun 2026
Signals of Gallstones: Recognizing Symptoms Before Complications Arise
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Liver
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “John Strang”